Preview

User

Not a user? Register with this site Forgot your password?

Cancer Urology

Advanced search
Fullscreen

For citations:

Menshikov K.V., Lipatov D.O., Nasretdinov A.F., Musin Sh.I., Sultanbaeva N.I., Menshikova I.A., Sultanbaev A.V., Izmaylov A.A., Galimov Sh.N., Rezyapova A.Sh. Lenvatinib and pembrolizumab combination in metastatic renal cell carcinoma: experience of the Republic of Bashkortostan. Cancer Urology. 2024;20(2):26-34. (In Russ.) https://doi.org/10.17650/1726-9776-2024-20-2-26-34



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

“ABV-press” publishing house
Research Institute of Carcinogenesis
Floor 3, 24 Kashirskoe Shosse, Build. 15,
Moscow 115478, Russian Federation
tel. +7 (499) 929-96-19,
E-mail: abv@abvpress.ru

Processing of personal data
supported by NEICON (Elpub lab)
X